TCOM Stock Analysis: Trip.com | NASDAQ
Travel Services | NASDAQ, USA | Market Cap: 25.459m USD | 12M Return: -47.4% | US89677Q1076 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 134M
EPS Trend: 83.0%
Qual. Beats: 0
Rev. Trend: 98.4%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Trip.com Group Limited (NASDAQ: TCOM) is a major online travel service provider headquartered in Singapore, operating across China and international markets. Through subsidiaries, the company offers a broad portfolio of travel services including accommodation reservation, transportation ticketing (air, train, long-distance bus, and ferry), packaged tours, in-destination products, and corporate travel management. It primarily acts as an agent for hotel bookings and air ticket sales, and operates under multiple well-known travel brands including Ctrip, Qunar, Trip.com, Travix, Travelfusion, and Skyscanner.
The company also generates ancillary revenue streams beyond traditional bookings, such as travel insurance, online check-in and seat selection, airport VIP lounge access, online advertising, and financial services targeting both consumers and ecosystem partners. Its corporate travel arm, Trip.Biz, delivers technology-enabled business travel management solutions, adding an enterprise-focused segment to its predominantly consumer-facing platform model. Founded in 1999 and formerly known as Ctrip.com International (renamed in October 2019), Trip.com is classified within the Consumer Discretionary sector and the Hotels, Resorts & Cruise Lines sub-industry.
- China outbound travel recovery fuels hotel and ticketing revenue
- Skyscanner international bookings drive diversification beyond China
- Competition from Meituan pressures hotel take rates and margins
| Net Income: 24.1b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -2.30 > 1.0 |
| NWC/Revenue: 46.22% < 20% (prev 50.73%; Δ -4.51% < -1%) |
| CFO/TA 0.06 > 3% & CFO 14.4b > Net Income 24.1b |
| Net Debt (-52.0b) to EBITDA (11.4b): -4.58 < 3 |
| Current Ratio: 1.33 > 1.5 & < 3 |
| Outstanding Shares: last quarter (632.3m) vs 12m ago -9.11% < -2% |
| Gross Margin: 80.05% > 18% (prev 80.86%; Δ -0.81% > 0.5%) |
| Asset Turnover: 25.53% > 50% (prev 22.69%; Δ 2.84% > 0%) |
| Interest Coverage Ratio: 19.96 > 6 (EBIT TTM 10.5b / Interest Expense TTM 527.7m) |
| A: 0.12 (Total Current Assets 123b - Total Current Liabilities 92.3b) / Total Assets 259b |
| B: 0.30 (Retained Earnings 76.6b / Total Assets 259b) |
| C: 0.04 (EBIT TTM 10.5b / Avg Total Assets 256b) |
| D: 1.62 (Book Value of Equity 159b / Total Liabilities 98.3b) |
| Altman-Z'' = 3.71 = AA |
| DSRI: 1.04 (Receivables 17.1b/14.4b, Revenue 65.3b/57.3b) |
| GMI: 1.01 (GM 80.86% / 80.05%) |
| AQI: 0.98 (AQ_t 0.50 / AQ_t-1 0.51) |
| SGI: 1.14 (Revenue 65.3b / 57.3b) |
| TATA: 0.04 (NI 24.1b - CFO 14.4b) / TA 259b) |
| Beneish M = -2.90 (Cap -4..+1) = A |
As of September 18, 2026, the stock is trading at USD 40.36 with a total of 3,906,413 shares traded. Over the past week, the price has changed by +4.29%, over one month by -10.01%, over three months by -13.63% and over the past year by -47.44%.
Current recommended Stop Loss: 39.00 (which is 3.4% or 1.2 ATR below the current price).
Trip.com has received a consensus analysts rating of 4.64. Therefore, it is recommended to buy TCOM.
- StrongBuy: 24
- Buy: 6
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 60.1 | 48.8% |
Market Cap CNY = 171b (25.5b USD * 6.7074 USD.CNY)
P/E Trailing = 7.8201
P/E Forward = 11.0619
P/S = 0.3881
P/B = 1.0038
P/EG = 2.3763
Revenue TTM = 65.3b CNY
EBIT TTM = 10.5b CNY
EBITDA TTM = 11.4b CNY
Long Term Debt = 630.0m CNY (from longTermDebt, last quarter)
Short Term Debt = 25.8b CNY (from shortTermDebt, last quarter)
Debt = 27.5b CNY (from shortLongTermDebtTotal, last quarter) + Leases 567.0m
Net Debt = -52.0b CNY (calculated: Debt 27.5b - CCE 79.5b)
Enterprise Value = 119b CNY (171b + Debt 27.5b - CCE 79.5b)
Interest Coverage Ratio = 19.96 (Ebit TTM 10.5b / Interest Expense TTM 527.7m)
EV/FCF = 8.75x (Enterprise Value 119b / FCF TTM 13.6b)
FCF Yield = 11.43% (FCF TTM 13.6b / Enterprise Value 119b)
FCF Margin = 20.80% (FCF TTM 13.6b / Revenue TTM 65.3b)
Net Margin = 36.97% (Net Income TTM 24.1b / Revenue TTM 65.3b)
Gross Margin = 80.05% ((Revenue TTM 65.3b - Cost of Revenue TTM 13.0b) / Revenue TTM)
Gross Margin QoQ = 79.83% (prev 79.45%)
Tobins Q-Ratio = 0.46 (Enterprise Value 119b / Total Assets 259b)
Interest Expense / Debt = 1.92% (Interest Expense 527.7m / Debt 27.5b)
Taxrate = 19.48% (5.85b / 30.1b)
NOPAT = 8.48b (EBIT 10.5b * (1 - 19.48%))
Current Ratio = 1.33 (Total Current Assets 123b / Total Current Liabilities 92.3b)
Debt / Equity = 0.17 (Debt 27.5b / totalStockholderEquity, last quarter 159b)
Debt / EBITDA = -4.58 (Net Debt -52.0b / EBITDA 11.4b)
Debt / FCF = -3.83 (Net Debt -52.0b / FCF TTM 13.6b)
Total Stockholder Equity = 166b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.44% (Net Income 24.1b / Total Assets 259b)
RoE = 14.56% (Net Income TTM 24.1b / Total Stockholder Equity 166b)
RoCE = 6.33% (EBIT 10.5b / Capital Employed (Equity 166b + L.T.Debt 630.0m))
RoIC = 4.48% (NOPAT 8.48b / Invested Capital 189b)
WACC = 7.00% (E(171b)/V(198b) * Re(7.88%) + D(27.5b)/V(198b) * Rd(1.92%) * (1-Tc(0.19)))
Discount Rate = 7.88% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -34.82 | Cagr: -2.92%
[DCF] Terminal Value 73.10% ; FCFF base≈15.8b ; Y1≈13.8b ; Y5≈11.2b
[DCF] Fair Price = 367.2 (EV 179b - Net Debt -52.0b = Equity 231b / Shares 629.7m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 83.00 | EPS CAGR: 33.20% | SUE: 0.01 | # QB: 0
Revenue Correlation: 98.43 | Revenue CAGR: 18.74% | SUE: 0.02 | # QB: 0
EPS current Quarter (2026-09-30): EPS=7.97 | Chg30d=+0.41% | Revisions=-25% | Analysts=11
EPS current Year (2026-12-31): EPS=24.38 | Chg30d=+0.12% | Revisions=-17% | GrowthEPS=-46.5% | GrowthRev=+8.0%
EPS next Year (2027-12-31): EPS=28.49 | Chg30d=-0.14% | Revisions=-17% | GrowthEPS=+16.9% | GrowthRev=+11.1%
[Analyst] Revisions Ratio: -30% (up=2, down=5)